1989
DOI: 10.1001/archpedi.1989.02150160111022
|View full text |Cite
|
Sign up to set email alerts
|

Use of Adrenergic Bronchodilators by Pediatric Allergists and Pulmonologists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
8
0

Year Published

1990
1990
2003
2003

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 8 publications
(1 reference statement)
0
8
0
Order By: Relevance
“…A 1989 survey of US pediatric pulmonologists and allergists reported that 86% of respondents recommended a trial of bronchodilators for infants with bronchiolitis. 34 Since that time, the use of bronchodilators for bronchiolitis has been the subject of several meta-analyses. Kellner et al 22 found a modest short-term improvement associated with bronchodilator use, whereas Flores and Horwitz 27 concluded that there is insufficient data to support their use.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A 1989 survey of US pediatric pulmonologists and allergists reported that 86% of respondents recommended a trial of bronchodilators for infants with bronchiolitis. 34 Since that time, the use of bronchodilators for bronchiolitis has been the subject of several meta-analyses. Kellner et al 22 found a modest short-term improvement associated with bronchodilator use, whereas Flores and Horwitz 27 concluded that there is insufficient data to support their use.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the conflicting evidence regarding bronchodilators for bronchiolitis, previous studies have demonstrated that physicians favor their use. 33,34 We found no published studies that examined the role of nasal suction in the treatment of bronchiolitis.…”
mentioning
confidence: 99%
“…When compared with Canada, 10,31 the US 32 or other countries in Europe, 9 far fewer paediatricians in Australia routinely use pharmaceutical agents in the management of AVB. This difference may be due to guidelines recently published in Australia by the APRG.…”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, Australia is one of the few countries who have published guidelines. In the absence of a consensus view, the management of AVB still differs widely from country to country 5,9,10,31–33 …”
Section: Discussionmentioning
confidence: 99%
“…Whether bronchodilators should be used in the treatment of this disease has remained subject to discussion (1,2). Previous work has shown that bronchodilator responses in bronchiolitis range from marked improvement to deterioration of lung function (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14).…”
mentioning
confidence: 99%